Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA.

BTP, Gilbert; D, Mongin; R, Aymon; K, Lauper; C, Laedermann; C, Perrier; R, Mueller; DS, Courvoisier; A, Finckh

doi:10.1136/bmjopen-2023-072300

Public

Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA.

Shared by NobleBlocks on Mar 12, 2024 • 12:00 AM UTC

Authors:

Gilbert BTP

Mongin D

Aymon R

Abstract

<h4>Objectives</h4>This observational study compares the effectiveness of baricitinib (BARI), a targeted synthetic disease-modifying antirheumatic drug (tsDMARD), with alternative biological DMARDs (bDMARDs) in patients with rheumatoid arthritis (RA), from a prospective, longitudinal cohort.<h4>Meth...

Subject

epidemiology

Rheumatology

Statistics & Research Methods

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!